ReNAgade Therapeutics Management Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire ReNAgade Therapeutics Management Inc.
Quantité totale PI 43
Rang # Quantité totale PI 33 279
Note d'activité PI 2,7/5.0    61
Rang # Activité PI 11 621
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

13 2
7 0
21 0
0
 
Dernier brevet 2025 - Constrained lipids and methods o...
Premier brevet 2022 - Lipid nanoparticles and methods ...
Dernière marque 2023 - CELEST
Première marque 2022 - RENAGADE THERAPEUTICS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and t...
Invention Fast-shedding polyethylene glycol lipids. The present disclosure provides PEG lipids and transfer...
Invention Improved gene editing system, guides, and methods. The present disclosure provides methods and co...
2024 Invention Constrained lipids and methods of use thereof. The present disclosure details various lipids, co...
Invention Nickase-retron template-based precision editing system and methods of use. Disclosed herein relat...
Invention Cyclic lipids and methods of use thereof. The present disclosure details various lipids, composi...
Invention Gene editing systems, compositions, and methods for treatment of vexas syndrome. in vivoex vivoex...
Invention Engineered retrons and methods of use. Disclosed are engineered retrons and methods of use such ...
Invention Gene editing systems and compositions for treatment of hemoglobinopathies and methods of using th...
Invention Delivery of gene editing systems and methods of use thereof. The present disclosure describes imp...
Invention Compositions and methods for optimizing tropism of delivery systems for rna. The present disclos...
2023 Invention Lipid nanoparticles and methods of use thereof. The present disclosure provides pharmaceutical c...
P/S Chemical and biological agents for scientific and research use, namely, lipids, lipid nanoparticl...
Invention Gene editing components, systems, and methods of use. The present disclosure provides methods and...
Invention Engineered retrons and methods of use. Disclosed are engineered retrons and methods of use such a...
Invention Pegylated lipid compounds and methods of use thereof. The present disclosure relates to PEGylated...
Invention Engineered retrons and methods of use. in vitroin vivoe.g.e.g., mammalian) cell.
Invention Constrained lipids and methods of use thereof. The present disclosure details various lipids, com...
Invention Nucleobase editing system and method of using same for modifying nucleic acid sequences. The disc...
Invention Gene editing components, systems, and methods of use. The present disclosure provides methods an...
Invention Cyclic lipids and lipid nanoparticles (lnp) for the delivery of nucleic acids or peptides for use...
2022 Invention Cyclic lipids and methods of use thereof. The present disclosure details various lipids, composit...
Invention Acyclic lipids and methods of use thereof. The present disclosure details various lipids, compos...
P/S Biochemicals, namely, protein-encoding nucleic acids in the nature of double-stranded and single-...
Invention Acyclic lipids and methods of use thereof. The present disclosure details various lipids, composi...
Invention Compositions and methods for optimizing tropism of delivery systems for rna. The present disclosu...
Invention Lipid nanoparticles and methods of use thereof. The present disclosure provides pharmaceutical co...